calcium channel, voltage-dependent, gamma subunit 3 |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
protein kinase C, epsilon |
PACLITAXEL |
Phorbol Ester |
19% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
THIORIDAZINE |
Calcium Channel Type L, Phenylalkylamine |
97% |
.443uM |
.431uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DILTIAZEM |
Calcium Channel Type L, Benzothiazepine |
97% |
.028uM |
.025uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOMIPHENE |
Calcium Channel Type L, Benzothiazepine |
96% |
.789uM |
.701uM |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CADMIUM ACETATE |
Protein Tyrosine Kinase, HER2 Receptor |
96% |
1.186uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
CADMIUM ACETATE |
Protein Tyrosine Kinase, HER2 Receptor |
96% |
1.186uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
HALOPROGIN |
Dopamine Transporter |
96% |
1.969uM |
1.565uM |
View
|
adrenergic receptor, alpha 2a |
HALOPROGIN |
Adrenergic alpha2A |
96% |
1.222uM |
.458uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
TROGLITAZONE |
Serotonin 5-HT2B |
96% |
1.312uM |
.835uM |
View
|
cholinergic receptor, muscarinic 1 |
GENTIAN VIOLET |
Muscarinic M1 |
96% |
1.095uM |
.264uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
VERAPAMIL |
Serotonin 5-HT2B |
96% |
.165uM |
.105uM |
View
|
histamine receptor H 1 |
MIANSERIN |
Histamine H1, Central |
96% |
.001506uM |
.000175uM |
View
|
adrenergic receptor, alpha 2b |
MEPAZINE |
Adrenergic alpha2B |
96% |
.397uM |
.181uM |
View
|
dopamine receptor D3 |
METHYSERGIDE |
Dopamine D3 |
96% |
.172uM |
.059uM |
View
|
Cytochrom P450-2C19 monooxygenase |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C19 Inhibition |
96% |
.5uM |
NoneNone |
View
|
histamine receptor H 1 |
MEPAZINE |
Histamine H1, Central |
96% |
.027uM |
.003126uM |
View
|
adrenergic receptor, alpha 2a |
RISPERIDONE |
Imidazoline I2, Central |
96% |
.02uM |
.013uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
RISPERIDONE |
Imidazoline I2, Central |
96% |
.02uM |
.013uM |
View
|
epidermal growth factor receptor |
LEVODOPA |
Protein Tyrosine Kinase, EGF Receptor |
96% |
2.88uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
DEXKETOPROFEN |
Cyclooxygenase COX-2 |
96% |
.23uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
DEXKETOPROFEN |
Cyclooxygenase COX-2 |
96% |
.23uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
SERTRALINE |
Adrenergic alpha2A |
96% |
.2888uM |
.1083uM |
View
|
cholinergic receptor, muscarinic 5 |
SERTRALINE |
Muscarinic M5 |
96% |
.5073uM |
.3645uM |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
DIGOXIN |
ATPase, Na+/K+ |
96% |
1.647uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
KETOTIFEN |
Muscarinic M5 |
96% |
.374uM |
.269uM |
View
|
adrenergic receptor, alpha 2b |
NORTRIPTYLINE |
Adrenergic alpha2C |
96% |
.203uM |
.03uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
NORTRIPTYLINE |
Adrenergic alpha2C |
96% |
.203uM |
.03uM |
View
|
estrogen receptor 1 |
NORETHINDRONE |
Estrogen ERalpha |
96% |
.808uM |
.231uM |
View
|
estrogen receptor 1 |
NORETHINDRONE |
Estrogen ERalpha |
96% |
.808uM |
.231uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
NORETHINDRONE |
Glucocorticoid |
96% |
.433uM |
.197uM |
View
|
adrenergic receptor, alpha 2a |
OXICONAZOLE |
Adrenergic alpha2A |
96% |
4.0827uM |
1.531uM |
View
|
cholinergic receptor, muscarinic 3 |
EBASTINE |
Muscarinic M3 |
96% |
.6475uM |
.1372uM |
View
|
cholinergic receptor, muscarinic 4 |
EBASTINE |
Muscarinic M4 |
96% |
.8279uM |
.1155uM |
View
|
dopamine receptor D3 |
RABEPRAZOLE |
Dopamine D3 |
96% |
2.326uM |
.79uM |
View
|
adrenergic receptor, alpha 2b |
CETYLPYRIDINIUM BROMIDE |
Adrenergic alpha2C |
96% |
1.497uM |
.217uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CETYLPYRIDINIUM BROMIDE |
Adrenergic alpha2C |
96% |
1.497uM |
.217uM |
View
|
A3 adenosine receptor |
CETYLPYRIDINIUM BROMIDE |
Adenosine A3 |
96% |
4.758uM |
2.689uM |
View
|
prostaglandin-endoperoxide synthase 2 |
VALDECOXIB |
Cyclooxygenase COX-2 |
96% |
.208uM |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
VALDECOXIB |
Cyclooxygenase COX-2 |
96% |
.208uM |
NoneNone |
View
|
adrenergic receptor, beta 2 |
SOTALOL |
Adrenergic beta2 |
96% |
.4339uM |
.2983uM |
View
|
adrenergic receptor, alpha 2b |
PHENTOLAMINE |
Adrenergic alpha2C |
96% |
.11uM |
.016uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
PHENTOLAMINE |
Adrenergic alpha2C |
96% |
.11uM |
.016uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
ASTEMIZOLE |
Serotonin 5-HT2A |
96% |
.02uM |
.005575uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
ASTEMIZOLE |
Serotonin 5-HT2C |
96% |
.179uM |
.094uM |
View
|
mu-opioid receptor MOR |
ASTEMIZOLE |
Opiate mu |
96% |
1.492uM |
.606uM |
View
|
adrenergic receptor, alpha 2b |
ASTEMIZOLE |
Adrenergic alpha2C |
96% |
1.959uM |
.285uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
MOSAPRIDE |
Serotonin 5-HT2B |
95% |
.2959uM |
.1883uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
VERAPAMIL |
Serotonin 5-HT2A |
95% |
.442uM |
.126uM |
View
|
adrenergic receptor, alpha 2a |
GUANFACINE |
Imidazoline I2, Central |
95% |
.045uM |
.03uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GUANFACINE |
Imidazoline I2, Central |
95% |
.045uM |
.03uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
MIANSERIN |
Serotonin 5-HT1A |
95% |
.872uM |
.498uM |
View
|
cholinergic receptor, muscarinic 5 |
MIANSERIN |
Muscarinic M5 |
95% |
.32uM |
.23uM |
View
|
Cytochrom P450-2C19 monooxygenase |
1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C19 Inhibition |
95% |
.8uM |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PROPRANOLOL |
Serotonin Transporter |
95% |
.38uM |
.202uM |
View
|
cholinergic receptor, muscarinic 3 |
QUINACRINE |
Muscarinic M3 |
95% |
1.255uM |
.266uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
SERTRALINE |
Adrenergic, Norepinephrine Transporter |
95% |
.9848uM |
.9766uM |
View
|
adrenergic receptor, alpha 1b |
SERTRALINE |
Adrenergic alpha1B |
95% |
.605uM |
.3349uM |
View
|
androgen receptor |
CYPROTERONE ACETATE |
Testosterone |
95% |
.047uM |
.031uM |
View
|
adrenergic receptor, beta 3 |
LEVOBUNOLOL |
Adrenergic beta3 |
95% |
.34uM |
.255uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
ORPHENADRINE |
Serotonin 5-HT2A |
95% |
.436uM |
.125uM |
View
|
adrenergic receptor, alpha 2b |
EBASTINE |
Adrenergic alpha2C |
95% |
.2757uM |
.0401uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
EBASTINE |
Adrenergic alpha2C |
95% |
.2757uM |
.0401uM |
View
|
lymphocyte protein tyrosine kinase (mapped) |
CETYLPYRIDINIUM BROMIDE |
Protein Tyrosine Kinase, Lck |
95% |
3.182uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
PHENTOLAMINE |
Serotonin 5-HT2C |
95% |
.396uM |
.207uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
PHENTOLAMINE |
Serotonin 5-HT2A |
95% |
.359uM |
.103uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
BENZETHONIUM CHLORIDE |
Serotonin 5-HT2A |
95% |
.129uM |
.037uM |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BENZETHONIUM CHLORIDE |
Serotonin Transporter |
95% |
2.438uM |
1.295uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
BENZETHONIUM CHLORIDE |
Calcium Channel Type L, Phenylalkylamine |
95% |
.452uM |
.439uM |
View
|
adrenergic receptor, alpha 2a |
PHENTOLAMINE |
Adrenergic alpha2A |
95% |
.006uM |
.00225uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
GUANFACINE |
Serotonin 5-HT2B |
74% |
2.098uM |
1.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
NISOLDIPINE |
Calcium Channel Type L, Dihydropyridine |
95% |
.000741uM |
.000476uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
TAMOXIFEN |
Calcium Channel Type L, Benzothiazepine |
95% |
1.44uM |
1.28uM |
View
|
opioid receptor, kappa 1 |
TAMOXIFEN |
Opiate kappa |
95% |
15.629uM |
6.252uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
ERGONOVINE |
Serotonin 5-HT1A |
95% |
.008126uM |
.004643uM |
View
|
opioid receptor, sigma 1 |
DICYCLOMINE |
Sigma1 |
95% |
.00489uM |
.002055uM |
View
|
opioid receptor, sigma 1 |
CLEMASTINE |
Sigma1 |
95% |
.034uM |
.014uM |
View
|
adrenergic receptor, alpha 2b |
CLEMASTINE |
Adrenergic alpha2B |
95% |
.311uM |
.142uM |
View
|
adrenergic receptor, alpha 2b |
CLOMIPRAMINE |
Adrenergic alpha2C |
95% |
1.413uM |
.205uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
CLOMIPRAMINE |
Adrenergic alpha2C |
95% |
1.413uM |
.205uM |
View
|
adrenergic receptor, beta 2 |
CARVEDILOL |
Adrenergic beta2 |
95% |
.000241uM |
.000166uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CARVEDILOL |
Calcium Channel Type L, Phenylalkylamine |
95% |
.389uM |
.378uM |
View
|
adrenergic receptor, alpha 2a |
FLUNARIZINE |
Adrenergic alpha2A |
95% |
.581uM |
.218uM |
View
|
adrenergic receptor, alpha 1a |
GUANABENZ |
Adrenergic alpha1A |
95% |
.391uM |
.158uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
PIPAMAZINE |
Serotonin 5-HT2B |
95% |
.049uM |
.031uM |
View
|
Cytochrom P450-2C19 monooxygenase |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C19 Inhibition |
95% |
.6uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
MONTELUKAST |
Adrenergic alpha2A |
95% |
3.919uM |
1.47uM |
View
|
opioid receptor, sigma 1 |
TRIHEXYPHENIDYL |
Sigma1 |
95% |
.108uM |
.045uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
CYPROHEPTADINE |
Serotonin 5-HT1A |
95% |
.122uM |
.07uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
PREDNISONE |
Glucocorticoid |
95% |
1.146uM |
.521uM |
View
|
Cytochrom P450-1A2 monooxygenase |
BENZO[A]PYRENE |
CYP450-1A2 Inhibition |
95% |
.04uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
AURANOFIN |
Adrenergic alpha2B |
95% |
.796uM |
.363uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
SULCONAZOLE |
Adrenergic, Norepinephrine Transporter |
95% |
2.027uM |
2.01uM |
View
|
estrogen receptor 1 |
BETA-ESTRADIOL 3-BENZOATE |
Estrogen ERalpha |
95% |
.065uM |
.018uM |
View
|
estrogen receptor 1 |
BETA-ESTRADIOL 3-BENZOATE |
Estrogen ERalpha |
95% |
.065uM |
.018uM |
View
|
adrenergic receptor, alpha 2b |
CELECOXIB |
Adrenergic alpha2B |
95% |
1.516uM |
.692uM |
View
|
dopamine receptor D1A |
AMITRIPTYLINE |
Dopamine D1 |
95% |
.355uM |
.178uM |
View
|
cholinergic receptor, muscarinic 5 |
AMOXAPINE |
Muscarinic M5 |
95% |
.856uM |
.615uM |
View
|
arachidonate 15-lipoxygenase, second type |
U-78517F |
Lipoxygenase 15-LO |
95% |
5.67uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
U-78517F |
Lipoxygenase 15-LO |
95% |
5.67uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
U-78517F |
Lipoxygenase 15-LO |
95% |
5.67uM |
NoneNone |
View
|